The U.S. Food and Drug Administration in 2019 approved intranasal esketamine to treat depression in adults. However, little data is available on the use of ketamine or esketamine to treat bipolar ...
May 28, 2024 — New research finds that binge-eating disorder symptoms may persist longer than once believed, finding 61 percent and 45 percent of individuals still experienced binge-eating ...